Pricing & Reimbursement for the Benelux Market
Pharmaceutical companies must deal with a continuously growing number of regulations and requirements. To bring new innovative medicinal products to patients rapidly, a focused and transparent market access strategy is a must. M.P.C.A. International is specialised in market access in the Benelux for pharmaceuticals and medical devices.
Our pricing & reimbursement service areas
Through our extensive network, we work with leading experts in all important strategic therapeutic areas to build market access strategies that enable faster patient access.
Strategic Counselling
We guide clients to the best market access route and pricing strategy. We build market access strategies enabling faster patient access to therapies — tailored to the specific Benelux regulatory and reimbursement environment.
Price Determination
We prepare and file national pricing dossiers. We set prices for optimal access and returns according to economic and international criteria — ensuring competitive positioning and compliance with local pricing regulations.
Reimbursement
We prepare and file reimbursement dossiers — navigating the complex requirements of Belgian, Dutch and Luxembourg reimbursement authorities to maximise patient access and ensure optimal reimbursement conditions.
Creating a favourable market environment
We create a favourable environment in which companies can dedicate their treatments for patients globally — through strategic governmental and public affairs across the Benelux.
Through our extensive network and deep understanding of the Benelux regulatory and political landscape, we advocate for conditions that support faster market access and optimal reimbursement for your products.
Discuss your market access strategyGovernmental affairs goals
Shortening duration for market access
Improving reimbursement conditions
Ensuring best pricing conditions
Faster patient access to therapies
Ready to define your Benelux market access strategy?
Our market access specialists will help you navigate the Benelux pricing and reimbursement landscape — ensuring faster patient access and optimal returns.